ATE387198T1 - Verfahren zur herstellung von 17-allyl-amino- geldanamycin (17-aag) und anderer ansamycine - Google Patents

Verfahren zur herstellung von 17-allyl-amino- geldanamycin (17-aag) und anderer ansamycine

Info

Publication number
ATE387198T1
ATE387198T1 AT02761732T AT02761732T ATE387198T1 AT E387198 T1 ATE387198 T1 AT E387198T1 AT 02761732 T AT02761732 T AT 02761732T AT 02761732 T AT02761732 T AT 02761732T AT E387198 T1 ATE387198 T1 AT E387198T1
Authority
AT
Austria
Prior art keywords
ansamycins
aag
allyl
moneyanamycin
amino
Prior art date
Application number
AT02761732T
Other languages
German (de)
English (en)
Inventor
Lin Zhang
Marcus F Boehm
Siead Zegar
Original Assignee
Conforma Therapeutic Corp
Lin Zhang
Marcus F Boehm
Siead Zegar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Conforma Therapeutic Corp, Lin Zhang, Marcus F Boehm, Siead Zegar filed Critical Conforma Therapeutic Corp
Application granted granted Critical
Publication of ATE387198T1 publication Critical patent/ATE387198T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/04—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D225/06—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT02761732T 2001-09-24 2002-09-18 Verfahren zur herstellung von 17-allyl-amino- geldanamycin (17-aag) und anderer ansamycine ATE387198T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32663901P 2001-09-24 2001-09-24
US33189301P 2001-11-21 2001-11-21

Publications (1)

Publication Number Publication Date
ATE387198T1 true ATE387198T1 (de) 2008-03-15

Family

ID=26985493

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02761732T ATE387198T1 (de) 2001-09-24 2002-09-18 Verfahren zur herstellung von 17-allyl-amino- geldanamycin (17-aag) und anderer ansamycine

Country Status (9)

Country Link
US (1) US7579462B2 (OSRAM)
EP (1) EP1435939B1 (OSRAM)
JP (1) JP2005504086A (OSRAM)
KR (1) KR20040054692A (OSRAM)
CN (1) CN100378079C (OSRAM)
AT (1) ATE387198T1 (OSRAM)
CA (1) CA2460498A1 (OSRAM)
DE (1) DE60225307T2 (OSRAM)
WO (1) WO2003026571A2 (OSRAM)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6872715B2 (en) 2001-08-06 2005-03-29 Kosan Biosciences, Inc. Benzoquinone ansamycins
JP2005504086A (ja) 2001-09-24 2005-02-10 コンフォーマ セラピューティクス コーポレーション １７−アリルアミノゲルダナマイシン（１７−ａａｇ）および他のアンサマイシン類を製造する方法
WO2003037860A2 (en) 2001-10-30 2003-05-08 Conforma Therapeutics Corporation Purine analogs having hsp90-inhibiting activity
CA2474508A1 (en) 2002-02-08 2003-08-14 Conforma Therapeutics Corporation Ansamycins having improved pharmacological and biological properties
US7138401B2 (en) 2003-09-18 2006-11-21 Conforma Therapeutics Corporation 2-aminopurine analogs having HSP90-inhibiting activity
CN102643233B (zh) 2003-12-23 2015-11-25 无限发现公司 用于治疗癌症的包含苯醌的安沙霉素类似物
KR101045324B1 (ko) * 2004-08-11 2011-06-30 한국생명공학연구원 젤다나마이신 유도체 및 그 생합성 방법
US7371906B2 (en) * 2004-08-24 2008-05-13 Eastman Kodak Company Process for photo-oxidative stability improvements
WO2006089207A2 (en) * 2005-02-18 2006-08-24 Abraxis Bioscience, Inc. Drugs with improved hydrophobicity for incorporation in medical devices
CA2602257A1 (en) 2005-03-30 2006-10-05 Conforma Therapeutics Corporation Alkynyl pyrrolopyrimidines and related analogs as hsp90-inhibitors
CA2603462A1 (en) * 2005-04-07 2006-10-09 Conforma Therapeutics Corporation Phospholipid-based pharmaceutical formulations and methods for producing and using same
US7648976B2 (en) * 2005-11-23 2010-01-19 Bristol-Myers Squibb Company 17-allylamino-17-demethoxygeldanamycin polymorphs and formulations
US20090042847A1 (en) * 2005-11-23 2009-02-12 Kosan Biosciences Incorporated 17-allylamino-17-demethoxygeldanamycin polymorphs and formulations
CN101360492A (zh) * 2005-12-01 2009-02-04 康福玛医药公司 含安莎霉素的组合物
KR100796637B1 (ko) * 2006-09-29 2008-01-22 한국생명공학연구원 젤다나마이신 유도체, 이의 약학적으로 허용가능한 염,이의 제조방법 및 이를 유효성분으로 함유하는 암 예방 및치료제
US8916552B2 (en) 2006-10-12 2014-12-23 Astex Therapeutics Limited Pharmaceutical combinations
US8883790B2 (en) 2006-10-12 2014-11-11 Astex Therapeutics Limited Pharmaceutical combinations
PE20081506A1 (es) * 2006-12-12 2008-12-09 Infinity Discovery Inc Formulaciones de ansamicina
KR100861697B1 (ko) * 2007-01-30 2008-10-07 한국생명공학연구원 Ａｈｂａ 생합성 유전자 변이주를 이용한 안사마이신유도체의 생산 방법 및 신규한 안사마이신 유도체
WO2010045442A1 (en) 2008-10-15 2010-04-22 Infinity Discovery, Inc. Ansamycin hydroquinone compositions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3595955A (en) * 1969-03-26 1971-07-27 Upjohn Co Geldanamycin and process for producing same
US4261989A (en) * 1979-02-19 1981-04-14 Kaken Chemical Co. Ltd. Geldanamycin derivatives and antitumor drug
CA2127457A1 (en) 1992-01-06 1993-07-22 Walter P. Cullen Process and uses for 4,5-dihydrogeldanamycin and its hydroquinone
US5387584A (en) 1993-04-07 1995-02-07 Pfizer Inc. Bicyclic ansamycins
EP0706516A1 (en) 1993-06-29 1996-04-17 Pfizer Inc. Ansamycin derivatives as antioncogene and anticancer agents
US5932566A (en) * 1994-06-16 1999-08-03 Pfizer Inc. Ansamycin derivatives as antioncogene and anticancer agents
US5883236A (en) * 1997-11-19 1999-03-16 Abbott Laboratories Process for N-desmethylating erythromycins and derivatives thereof
EP1169319A4 (en) 1999-04-09 2005-02-09 Sloan Kettering Institutefor C METHODS AND COMPOSITIONS FOR DEGRADING AND / OR INHIBITING TYROSINE KINASES BELONGING TO THE HER FAMILY
JP2005504086A (ja) 2001-09-24 2005-02-10 コンフォーマ セラピューティクス コーポレーション １７−アリルアミノゲルダナマイシン（１７−ａａｇ）および他のアンサマイシン類を製造する方法
EP1923061A1 (en) 2001-09-24 2008-05-21 Conforma Therapeutic Corporation Process for preparing 17-Allyl amino geldanamycin (17-AAG) and other ansamycins

Also Published As

Publication number Publication date
DE60225307D1 (de) 2008-04-10
US20050176695A1 (en) 2005-08-11
WO2003026571A3 (en) 2003-10-02
EP1435939A2 (en) 2004-07-14
JP2005504086A (ja) 2005-02-10
CA2460498A1 (en) 2003-04-03
EP1435939B1 (en) 2008-02-27
WO2003026571A2 (en) 2003-04-03
CN1558757A (zh) 2004-12-29
CN100378079C (zh) 2008-04-02
US7579462B2 (en) 2009-08-25
KR20040054692A (ko) 2004-06-25
EP1435939A4 (en) 2004-12-29
DE60225307T2 (de) 2009-03-19

Similar Documents

Publication Publication Date Title
ATE387198T1 (de) Verfahren zur herstellung von 17-allyl-amino- geldanamycin (17-aag) und anderer ansamycine
DK1787980T3 (da) Krystallint og rent modafinil og fremgangsmåde til atfremstille dette
DE60201480D1 (de) Verfahren zur Herstellung von hochreinem Xylylendiamin
DE60325188D1 (de) Verfahren zur herstellung von sterilen, stabilisierten nanodispersionen
DE50211242D1 (de) Vorrichtung und Verfahren zur Herstellung von im Wesentlichen halogenfreien Trialkoxysilanen
ATE453648T1 (de) Verfahren zur herstellung von hexahydrofuroc2,3- büfuran-3-ol
DE60323994D1 (de) Verfahren zur herstellung von 2-chlor-1,1,1,2,3,3,3-heptafluorpropan, hexafluorpropen und 1,1,1,2,3,3,3-heptafluorpropan
DE60303268D1 (de) Verfahren und Vorrichtung zur Herstellung von Microarrays
DE60209584D1 (de) Verfahren und Vorrichtung zur Herstellung von Metallen hoher Reinheit durch verbesserte Raffinierung
DE60304109D1 (de) Verfahren zur Herstellung von Ringelementen und Vorrichtung zu dessen Durchführung
ATE455778T1 (de) Verfahren zur herstellung form i von (s)-(+)- clopidogrelbisulfat
ATE361334T1 (de) Verfahren zur herstellung von hochreinem polycarbonat
ATE400560T1 (de) Verfahren zur herstellung von 10,11 dihydro 10 hydroxy 5h-dibenz/b,f/azepin-5-carbonsäureamid und 10,11 dihydro 10 oxo-5h-dibenz/b,f/azepin-5 carbonsäureamid
DE60124289D1 (de) Verfahren zur herstellung von 21-hydroxy-6,19-oxidoprogesteron (21oh-6op)
DE60220554D1 (de) Mikrowelleninduzierter prozess zur herstellung von substituierten 4-vinylphenolen
DE60223279D1 (de) Verfahren für die herstellung substituierter bicyclischer derivate zur behandlung von anomalem zellwachstum
DE60210778D1 (de) Verfahren zur herstellung von 4-amino-2,5-bisheterocyclylchinazolinen
DE69808771D1 (de) Ein verfahren zur herstellung von tetraaza makrocyclen
ATE374757T1 (de) Verfahren zur herstellung von (1,4,5)- oxadiazepinderivaten
ATE385232T1 (de) Verfahren zur herstellung von 3, 3', 6, 6'- tetraalkylen-2, 2'-biphenolen und 3, 3', 6, 6'- tetraalkylen-5, 5'-dihalo-2, 2' biphenolen
ATE496038T1 (de) Verfahren zur herstellung von quetiapin
DE60003807D1 (de) Enantiomere von mercaptolactonen und verfahren zu ihrer herstellung
ATE374755T1 (de) Verfahren zur herstellung von 1,3,5- triazincarbamaten und -harnstoffen
ATE325794T1 (de) Verfahren zur herstellung und zwischenprodukte von pyridin-2-yl-amin
ATE501162T1 (de) Neues verfahren und zwischenprodukte zur herstellung von 19-nor-steroiden

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1435939

Country of ref document: EP

REN Ceased due to non-payment of the annual fee